CADL Competitors & Alternatives
Compare Candel Therapeutics Inc with similar stocks in the same industry
Biotechnology
CADL
Main Stock$11.02
Tradestie Score
57
Market Cap
$304.12M
Analyst Upside
+90.6%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$5.05
|
$879.90M | 6.4 | 48 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$7.69
|
$871.90M | - | 53 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.07
|
$867.49M | - | 54 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$19.97
|
$864.42M | - | 44 | Compare |
|
CRMD
CorMedix Inc.
|
$7.82
|
$862.55M | 3.6 | 43 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$38.44
|
$847.12M | - | 62 | Compare |
|
XNCR
Xencor, Inc.
|
$23.71
|
$843.75M | - | 38 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$27.75
|
$841.74M | - | 64 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$32.77
|
$832.47M | - | 60 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$43.49
|
$824.20M | - | 64 | Compare |
More CADL Analysis
Data updated: Sep 17, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry